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Sporothrix schenkii sensu lato is a rare cause of arthritis. Its course is indolent with lack of constitutional symptoms resulting in
delayed presentation and diagnosis. It is a dimorphic fungus found ubiquitously in sphagnum moss, decaying vegetation, soil, and
hay. Inoculation of dirt into the skin and soft tissues and, in rare instances, inhalation of aerosolized conidia from soil and plants
can lead to infection. Subacute and chronic involvement of skin and subcutaneous tissues is the most common manifestation of
sporotrichosis in immunocompetent hosts. In patients with underlying risk factors (HIV, alcoholism, diabetes mellitus, organ
transplant patients, immunosuppressive medications, steroids, and malignancies), it can often have disseminated visceral,
osteoarticular, meningeal, and pulmonary involvement. Sporothrical arthritis most commonly infects knee joint followed by hand
and wrist joints. A culture of Sporothrix schenkii sensu lato is the gold standard for the diagnosis of sporotrichosis. Itraconazole is
the drug of choice for osteoarticular sporotrichosis. We present a case of sporotrichal arthritis in a patient without skin or lymph
node involvement who underwent treatment with itraconazole resulting in resolution of his symptoms.

1. Case Presentation
A 33-year-old male taxi driver with past medical history
signiﬁcant only for alcoholism, presented to his family physician’s oﬃce with the chief complaint of left knee pain and
swelling for nine months. He denied any speciﬁc injury,
puncture wound, or any systemic symptoms. He denied
contact with animals. Examination of his left knee demonstrated a moderate-to-severe eﬀusion. He was not tender to
palpation across his bony prominences. He had no medial or
lateral joint line tenderness. He had a range of motion that was
full and symmetric with that of the contralateral side. He had
a negative McMurray’s sign. His knee was stable to ligamentous examination. There was no erythema or lymphadenopathy. X-ray of the left knee showed a joint eﬀusion.
MRI of his left knee also demonstrated a joint eﬀusion with
a popliteal cyst and synovial thickening (Figure 1).
He subsequently underwent aspiration of the eﬀusion in
the oﬃce. Synovial ﬂuid was cloudy yellow and blood-tinged.

Fluid analysis showed the following: RBC: 50,200 cells/mcL,
WBC: 4900 cells/mcL (ref range < 150/mcL), PMN: 34% (ref
range 0–25%), lymphocytes: 54%, and monocyte: 10%; no
crystals were observed, and pathological exam was consistent
with hemorrhagic ﬂuid with acute and chronic inﬂammation.
Bacterial culture did not demonstrate any growth, but fungal
cultures grew branching narrow hyphae with septations and
conidia in a bouquet-like appearance leading to a presumptive
diagnosis of Sporothrix schenkii (Figure 2). The patient was
admitted to the University of Kansas Hospital for further
management.
The patient underwent diagnostic left knee arthroscopy,
irrigation, debridement, and major synovectomy. There was
no internal derangement of the knee. There was no chondral
injury. He had no evidence of a medial-lateral meniscus tear.
His anterior cruciate ligament was intact. There was signiﬁcant synovial thickening throughout. Blood counts, liver
biochemistry, coagulation parameters, and renal and thyroid
functions were normal except for elevated liver function tests
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Figure 1: MRI (axial view) of left knee showing synovial thickening
(arrow).

Figure 3: Histopathologic features of excisional biopsy. H/Estained sections demonstrate mixed chronic inﬂammation composed of plasma cells and lymphocytes. Scattered granulomas are
present with central necrosis (×200).
Table 1: Results of antifungal susceptibility testing.
Drugs
Amphotericin B
Fluconazole
Itraconazole
Posaconazole
Voriconazole
Terbinaﬁne

Figure 2: A hyphal form of Sporothrix schenkii from synovial ﬂuid
aspirate cultured on Sabouraud agar. Narrow branching hyphae
(red arrows) giving rise to slender conidiophores (white arrows) at
right angles. The apex of conidiophores is covered with tear-shaped
conidia in a rosette-like fashion (black arrows). Single conidia can
also be formed along the hyphae.

consistent with his history of alcohol use. ESR and CRP were
within normal limits, HIV test was negative, and immunodeﬁciency workup (humoral immunodeﬁciency, phagocytic disorders, and T-cell immunodeﬁciencies) was
unrevealing. Abdominal CT done to evaluate for disseminated disease showed marked diﬀuse hepatic steatosis. After
the debridement, the patient was started on oral itraconazole
200 mg twice daily with a plan to treat for 12 months.
Synovial biopsies obtained during debridement from the
suprapatellar pouch were sent for both microbiology and
pathology. Surgical cultures on Sabouraud dextrose agar
grew Sporothrix schenkii within four days conﬁrming the
initial diagnosis. The identiﬁcation was conﬁrmed by
matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry—MALDI-TOF MS (Bruker Daltonics
Biotyper Microﬂex LT).
All other microbiological investigations of eﬀusion samples including routine bacterial cultures, acid-fast bacilli (AFB)

Results (μg/ml)
1
>64
1
0.5
>16
0.008

cultures, were ultimately negative for any growth. Blood
cultures multiple times did not reveal any growth. Pathology of
the synovial tissue showed prominent mixed chronic inﬂammation composed of plasma cells and lymphocytes. There
were scattered granulomas with central necrosis. Fite’s acidfast staining was negative for acid-fast bacilli. GMS stain was
negative for fungal organisms (Figure 3).
Antifungal susceptibility assays were performed by the
broth microdilution method according to the guidelines
recommended by the Clinical Laboratory Standards Institute (CLSI): documents M38-A2 (CLSI, 2002b) (Table 1).
During his subsequent follow-up visits, he reported that
all his symptoms (knee swelling and pain) had improved
with itraconazole, but unfortunately, he continued to drink
excessive amounts of alcohol.

2. Discussion
Sporotrichosis was ﬁrst diagnosed by Schenck in 1896 at
Johns Hopkins Hospital from a 36-year-old male patient
presenting with right hand and arm lesions [1]. Sporothrix
schenkii sensu lato is a dimorphic fungus. At 25–30°C (in the
environment or the laboratory), the organism grows as
a mold. The hyphae are narrow with septations and
branching with tapering conidiophores rising at right angles.
The apex of conidiophores carries many tear-shaped and
round conidia in a bouquet-like appearance forming rosettelike structures. In vivo at 35–37°C, Sporothrix schenkii
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creates yeast-like colonies comprising round, oval, or fusiform budding cells [2]. Sporothrix schenkii sensu lato is
a complex comprising four related species: S. schenckii sensu
stricto, S. brasiliensis, S. globosa, and S. lurei. S. schenckii
sensu stricto is the most common species associated with
human diseases [3, 4]. In our case, no molecular identiﬁcation was made; therefore, it is necessary to call it Sporothrix schenkii sensu lato.
The organism grows densely in sphagnum moss,
decaying vegetation, soil, and hay. People involved in outdoor activities are at high risks like gardeners, nursery
workers, farmers, and miners. Accidents that lead to inoculation of soil into the skin and soft tissues can lead to
infection. History of trauma is not always present [5]. As in
this case, probably the inoculation happened through microscopic breaks in the skin or through small injuries the
patient did not remember. There are some cases when
Sporothrix schenkii sensu lato caused disease through intact
skin when inoculum was large. In those cases, the infection
was acquired through contact with cats [6, 7]. Sporothrix
schenkii sensu lato can also be transmitted through animal
bites and scratches. In cases of pulmonary sporotrichosis, the
mode of transmission is through inhalation of aerosolized
conidia from soil and vegetations [5].
Subacute and chronic involvement of the skin and
subcutaneous tissues is the most common manifestation of
sporotrichosis in immunocompetent hosts. The inoculum
load and virulence factors of the strain, immune status of the
patient, as well as the depth of inoculation determine the
various clinical forms of sporotrichosis [8]. In patients with
underlying risk factors (HIV, alcoholism, diabetes mellitus,
organ transplant recipients, malignancies, and use of immunosuppressive medications or steroids), it can often have
disseminated visceral, osteoarticular, meningeal, and pulmonary involvement [5, 9, 10]. Excessive amounts of alcohol
consumption is an important risk factor. Bayer et al. described 44 cases of sporotrichal arthritis, of which 38% were
alcoholics. In another report by Howell et al., 10 out of 13
cases of sporotrichal arthritis had a history of signiﬁcant
alcohol intake [11, 12]. Osteoarticular disease is rare representing 3-4% of cases, most often aﬀecting patients with
alcoholism as is the case with our patient [11–14]. It is the
most common extracutaneous form of sporotrichosis [15].
Its course is indolent with lack of constitutional symptoms
resulting in delayed presentation and diagnosis [11].
Osteoarticular form can either follow skin inoculation or
results from hematogenous spread from the lungs. Isolated
involvement of joints without skin lesions is rare. Septic
arthritis is more common than osteomyelitis. Sporotrichosis
most commonly infects the knee joint followed by hand and
wrist joints [11, 13]. It has a propensity to aﬀect small joints
in the hands and the wrist in contrast to other fungal
arthritides (Candida and Coccidioides) [11, 13, 16]. It can be
monoarticular (more common in immunocompetent hosts)
or polyarticular. Other manifestations of osteoarticular
sporotrichosis include granulomatous tenosynovitis and
bursitis [8, 17, 18].
Patients with sporotrichal arthritis usually present with
joint swelling, tenderness, restricted range of motion, and
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stiﬀness. Only a minority of patients have positive constitutional signs, fever, and leukocytosis. Elevated erythrocyte
sedimentation rate is common [19]. The course is indolent with
an average time to diagnosis of 17 months. The most common
abnormality on X-ray is osteoporosis of contiguous bony
surfaces followed by soft tissue and parasynovial swelling,
cartilage erosion, and punched-out bony lesions [11].
Culture is the gold standard for the diagnosis of sporotrichosis. It consists of isolating the organism from
a clinical specimen. Sabouraud dextrose agar is the medium
of choice. Within days to weeks (in 89% of cases within eight
days), hyphal growth appears at room temperature with
characteristic appearance of conidia (bouquet-like or
rosette-like structures) resulting in the presumptive identiﬁcation of Sporothrix schenkii sensu lato [5, 20]. For deﬁnitive diagnosis, conversion to the yeast form is required by
subculturing the organism on special media like brain heart
infusion agar, chocolate agar, or blood agar at 35 to 37°C for
5 to 7 days [8, 21]. Another method of identiﬁcation and
diﬀerentiation of closely related Sporothrix species is by
ribosomal protein analysis (obtained directly from fungal
cells) using matrix-assisted laser desorption/ionization timeof-ﬂight mass spectrometry—MALDI-TOF MS [22].
Histopathologic examination usually reveals mixed granulomatous and pyogenic inﬂammation with multinucleated
giant cells. The typical lesion is noncaseating granulomatous
synovitis, but in some cases, caseating granulomas are seen
mimicking tuberculous arthritis. The organisms are frequently
present in small numbers, so clinical specimens from patients
infected with Sporothrix schenkii sensu lato often demonstrates
no fungal elements. Either 10% potassium hydroxide, ﬂuorescent antibody staining, Gram stain, or Giemsa stain can be
used, but the sensitivity is low. If yeast forms are present, they
are usually round, oval, cigar-shaped, or fusiform budding cells
[5, 11, 23].
Microdilution test proposed by Clinical Laboratory
Standards Institute (CLSI) is the most commonly used
susceptibility method standardized for Sporothrix schenkii
sensu lato. Even though no MIC breakpoints for dimorphic
fungi have been established, isolates with MIC < 1 g/ml can
be considered susceptible for analytical purposes only [24].
Itraconazole (200 mg twice daily by mouth for at least 12
months) is the drug of choice for osteoarticular sporotrichosis
according to the most recent guidelines [25]. Osteoarticular
sporotrichosis has a less favorable response rate to itraconazole
compared with cutaneous or lymphocutaneous sporotrichosis
[26–30]. All forms of sporotrichosis respond to ﬂuconazole
suboptimally [29, 30]. Amphotericin B can be used in extensive or itraconazole-unresponsive disease with similar efﬁcacy but with more side eﬀects [11]. Surgical debridement
alone is not eﬀective, and it is not commonly used. In most of
the cases, surgical therapy was performed for diagnostic
purposes as in our case [11, 25].
The rarity of isolated (without skin and lymph node)
involvement of joints in sporotrichosis as well as the lack of
yeast forms in biopsy specimens results in a delay in diagnosis and subsequently in suboptimal treatment leading to
permanent disability and high morbidity. Sporotrichal arthritis should be included in the diﬀerential diagnosis of
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chronic monoarthritis or polyarthritis in patients with highrisk factors and occupation.

Case Reports in Infectious Diseases

[18]

Conflicts of Interest
The authors declare that they have no conﬂicts of interest.

[19]
[20]

References
[1.] B. R. Schenck, “Refractory subcutaneous abscesses caused by
a fungus possibly related to the sporoctrichia,” Bulletin of the
Johns Hopkins Hospital, vol. 9, pp. 286–290, 1898.
[2.] D. H. Larone, Medically Important Fungi: A Guide to
Identiﬁcation, ASM Press, Washington, DC, USA, 5th edition, 2018.
[3.] A. M. Rodrigues, G. S. de Hoog, and Z. P. de Camargo,
“Molecular diagnosis of pathogenic Sporothrix species,”
Neglected Tropical Diseases, vol. 9, no. 12, p. e0004190, 2015.
[4.] A. Chakrabarti, A. Bonifaz, M. C. Gutierrez-Galhardo,
T. Mochizuki, and S. Li, “Global epidemiology of sporotrichosis,” Medical Mycology, vol. 53, no. 1, pp. 3–14, 2015.
[5.] C. A. Kauﬀman, “Sporotrichosis,” Clinical Infectious Diseases,
vol. 29, pp. 231–237, 1999.
[6.] B. P. Nusbaun, N. Gulbas, and S. N. Horwitz, “Sporotrichosis
acquired from a cat,” Journal of the American Academy of
Dermatology, vol. 8, no. 3, pp. 386–391, 1983.
[7.] S. I. Read and L. C. Sperling, “Feline sporotrichosis: transmission to man,” Archives of Dermatology, vol. 118, no. 6,
pp. 429–431, 1982.
[8.] M. B. de Lima Barros, R. de Almeida Paes, and A. O. Schubach,
“Sporothrix schenckii and sporotrichosis,” Clinical Microbiology
Reviews, vol. 24, no. 4, pp. 633–654, 2011.
[9.] G. S. Gottlieb, C. F. Lesser, K. K. Holmes, and A. Wald,
“Disseminated sporotrichosis associated with treatment with
immunosuppressants and tumor necrosis factor-alpha antagonists,” Clinical Infectious Diseases, vol. 37, no. 6, pp. 838–840,
2003.
[10.] R. M. Gullberg, A. Quintanilla, M. L. Levin, J. Williams, and
J. P. Phair, “Sporotrichosis: recurrent cutaneous, articular, and
central nervous system infection in a renal transplant recipient,”
Reviews of Infectious Diseases, vol. 9, pp. 369–375, 1987.
[11.] A. S. Bayer, V. J. Scott, and L. B. Guze, “Fungal arthritis. III.
Sporotrichal arthritis,” Seminars in Arthritis and Rheumatism, vol. 9, no. 1, pp. 66–74, 1979.
[12.] S. J. Howell and J. S. Toohey, “Sporotrichal arthritis in southcentral Kansas,” Clinical Orthopaedics and Related Research,
vol. 346, pp. 207–214, 1998.
[13.] J. E. Crout, N. S. Brewer, and R. B. Tompkins, “Sporotrichosis
arthritis: clinical features in seven patients,” Annals of Internal Medicine, vol. 86, no. 3, pp. 294–297, 1977.
[14.] H. I. Lurie, “Five unusual cases of sporotrichosis from South
Africa showing lesions in muscles, bones, and viscera,” British
Journal of Surgery, vol. 50, no. 224, pp. 585–591, 1963.
[15.] D. E. Wilson, J. J. Mann, J. E. Bennett, and J. P. Utz, “Clinical
features of extracutaneous sporotrichosis,” Medicine, vol. 46,
no. 3, pp. 265–279, 1967.
[16] P. C. Altner and R. R. Turner, “Sporotrichosis of bones and
joints. Review of the literature and report of six cases,”
Clinical Orthopaedics and Related Research, vol. 68, no. 1,
pp. 138–148, 1970.
[17] C. W. Stratton, K. A. Lichtenstein, S. R. Lowenstein,
D. B. Phelps, and L. B. Reller, “Granulomatous tenosynovitis
and carpal tunnel syndrome caused by Sporothrix schenckii,”

[21]
[22]

[23]
[24]

[25]

[26]

[27]

[28]

[29]

[30]

American Journal of Medicine, vol. 71, no. 1, pp. 161–164,
1981.
D. A. Schwartz, “Sporothrix tenosynovitis—diﬀerential diagnosis of granulomatous inﬂammatory disease of the joints,”
Journal of Rheumatology, vol. 16, pp. 550–553, 1989.
G. N. Yacobucci and M. D. Santilli, “Sporotrichosis of the
knee. A case report,” Orthopedics, vol. 9, pp. 387–390, 1986.
P. G. Pappas, I. Tellez, A. E. Deep, D. Nolasco, W. Holgado,
and B. Bustamante, “Sporotrichosis in Peru: description of an
area of hyperendemicity,” Clinical Infectious Diseases, vol. 30,
no. 1, pp. 65–70, 2000.
K. J. Kwon-Chung and J. E. Bennett, Sporotrichosis: Medical
Mycology, Lea & Febiger, Philadelphia, PA, USA, 1992.
M. M. Oliveira, C. Santos, P. Sampaio et al., “Development
and optimization of a new MALDI-TOF protocol for identiﬁcation of the Sporothrix species complex,” Research in
Microbiology, vol. 166, no. 2, pp. 102–110, 2015.
R. Morris-Jones, “Sporotrichosis,” Clinical and Experimental
Dermatology, vol. 27, no. 6, pp. 427–431, 2002.
Clinical and Laboratory Standards Institute, Reference
Method for Broth Dilution Antifungal Susceptibility Testing of
Filamentous Fungi; Approved Standard, Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2nd edition,
2008.
C. A. Kauﬀman, B. Bustamante, S. W. Chapman, and
P. G. Pappas, “Infectious Diseases Society of America.
Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of
America,” Clinical Infectious Diseases, vol. 45, no. 10,
pp. 1255–1265, 2007.
R. E. Winn, J. Anderson, J. Piper, N. E. Aronson, and J. Pluss,
“Systemic sporotrichosis treated with itraconazole,” Clinical
Infectious Diseases, vol. 17, no. 2, pp. 210–217, 1993.
A. Restrepo, J. Robledo, I. Gomez, A. M. Tabares, and
R. Gutierrez, “Itraconazole therapy in lymphangitic and cutaneous sporotrichosis,” Archives of Dermatology, vol. 122, no. 4,
pp. 413–417, 1986.
P. K. Sharkey-Mathis, C. A. Kauﬀman, J. R. Graybill et al.,
“Treatment of sporotrichosis with itraconazole. NIAID
Mycoses Study Group,” American Journal of Medicine,
vol. 95, no. 3, pp. 279–285, 1993.
I. A. Conti Diaz, E. Civila, E. Gezuele et al., “Treatment of
human cutaneous sporotrichosis with itraconazole,” Mycoses,
vol. 35, no. 5-6, pp. 153–156, 2009.
C. A. Kauﬀman, P. G. Pappas, D. S. McKinsey et al., “Treatment
of lymphocutaneous and visceral sporotrichosis with ﬂuconazole,” Clinical Infectious Diseases, vol. 22, no. 1, pp. 46–50, 1996.

MEDIATORS
of

INFLAMMATION

The Scientific
World Journal
Hindawi Publishing Corporation
http://www.hindawi.com
www.hindawi.com

Volume 2018
2013

Gastroenterology
Research and Practice
Hindawi
www.hindawi.com

Volume 2018

Journal of

Hindawi
www.hindawi.com

Diabetes Research
Volume 2018

Hindawi
www.hindawi.com

Volume 2018

Hindawi
www.hindawi.com

Volume 2018

International Journal of

Journal of

Endocrinology

Immunology Research
Hindawi
www.hindawi.com

Disease Markers

Hindawi
www.hindawi.com

Volume 2018

Volume 2018

Submit your manuscripts at
www.hindawi.com
BioMed
Research International

PPAR Research
Hindawi
www.hindawi.com

Hindawi
www.hindawi.com

Volume 2018

Volume 2018

Journal of

Obesity

Journal of

Ophthalmology
Hindawi
www.hindawi.com

Volume 2018

Evidence-Based
Complementary and
Alternative Medicine

Stem Cells
International
Hindawi
www.hindawi.com

Volume 2018

Hindawi
www.hindawi.com

Volume 2018

Journal of

Oncology
Hindawi
www.hindawi.com

Volume 2018

Hindawi
www.hindawi.com

Volume 2013

Parkinson’s
Disease

Computational and
Mathematical Methods
in Medicine
Hindawi
www.hindawi.com

Volume 2018

AIDS

Behavioural
Neurology
Hindawi
www.hindawi.com

Research and Treatment
Volume 2018

Hindawi
www.hindawi.com

Volume 2018

Hindawi
www.hindawi.com

Volume 2018

Oxidative Medicine and
Cellular Longevity
Hindawi
www.hindawi.com

Volume 2018

